Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Homeodomain Proteins | 17 | 2020 | 554 | 1.690 |
Why?
|
Drosophila Proteins | 21 | 2020 | 498 | 1.610 |
Why?
|
Drosophila melanogaster | 21 | 2020 | 605 | 1.530 |
Why?
|
Transcription Factors | 22 | 2020 | 1647 | 1.240 |
Why?
|
Enhancer Elements, Genetic | 9 | 2014 | 280 | 1.020 |
Why?
|
Body Patterning | 7 | 2015 | 216 | 0.890 |
Why?
|
Drosophila | 8 | 2010 | 511 | 0.760 |
Why?
|
Bladder Exstrophy | 6 | 2017 | 10 | 0.740 |
Why?
|
Evolution, Molecular | 7 | 2014 | 836 | 0.550 |
Why?
|
Gene Expression Regulation, Developmental | 12 | 2020 | 659 | 0.550 |
Why?
|
DNA-Binding Proteins | 7 | 2020 | 1240 | 0.540 |
Why?
|
Nuclear Proteins | 5 | 2018 | 726 | 0.510 |
Why?
|
Genetic Variation | 6 | 2016 | 1369 | 0.500 |
Why?
|
Molecular Sequence Data | 18 | 2014 | 3029 | 0.490 |
Why?
|
Penetrance | 2 | 2015 | 45 | 0.480 |
Why?
|
Binding Sites | 11 | 2014 | 1113 | 0.460 |
Why?
|
Bacterial Proteins | 5 | 2001 | 885 | 0.450 |
Why?
|
MafB Transcription Factor | 1 | 2013 | 6 | 0.450 |
Why?
|
Osteolysis | 1 | 2013 | 14 | 0.450 |
Why?
|
Base Sequence | 14 | 2014 | 2331 | 0.350 |
Why?
|
Epispadias | 4 | 2014 | 5 | 0.340 |
Why?
|
Embryo, Mammalian | 5 | 2020 | 221 | 0.340 |
Why?
|
Animals | 39 | 2020 | 27233 | 0.320 |
Why?
|
Amino Acid Sequence | 10 | 2013 | 2062 | 0.300 |
Why?
|
Insect Proteins | 3 | 2003 | 88 | 0.300 |
Why?
|
LIM-Homeodomain Proteins | 2 | 2017 | 21 | 0.270 |
Why?
|
Polymorphism, Genetic | 5 | 2014 | 825 | 0.270 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 661 | 0.260 |
Why?
|
Wnt3 Protein | 2 | 2015 | 14 | 0.250 |
Why?
|
Repressor Proteins | 4 | 2020 | 419 | 0.250 |
Why?
|
Exons | 3 | 2005 | 452 | 0.250 |
Why?
|
Genes, Insect | 6 | 2015 | 183 | 0.240 |
Why?
|
Anus, Imperforate | 2 | 2015 | 11 | 0.240 |
Why?
|
Biological Evolution | 3 | 2011 | 950 | 0.240 |
Why?
|
DNA Helicases | 2 | 2020 | 84 | 0.240 |
Why?
|
Mutation | 9 | 2016 | 4097 | 0.230 |
Why?
|
Genetic Predisposition to Disease | 4 | 2017 | 2322 | 0.230 |
Why?
|
Tumor Suppressor Proteins | 3 | 2017 | 289 | 0.220 |
Why?
|
Proinsulin | 2 | 2013 | 124 | 0.220 |
Why?
|
Sequence Alignment | 5 | 2014 | 353 | 0.220 |
Why?
|
Hypospadias | 1 | 2003 | 5 | 0.220 |
Why?
|
Fanconi Syndrome | 1 | 2003 | 3 | 0.220 |
Why?
|
DNA, Intergenic | 1 | 2002 | 26 | 0.220 |
Why?
|
Chloride Channels | 1 | 2003 | 42 | 0.220 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2003 | 35 | 0.210 |
Why?
|
Bacillus subtilis | 2 | 2001 | 89 | 0.210 |
Why?
|
Pedigree | 5 | 2013 | 968 | 0.210 |
Why?
|
Hand Deformities | 1 | 2002 | 1 | 0.210 |
Why?
|
Foot Deformities | 1 | 2002 | 6 | 0.210 |
Why?
|
Protein Conformation | 4 | 2015 | 884 | 0.210 |
Why?
|
Peptides | 2 | 2004 | 646 | 0.210 |
Why?
|
Urogenital Abnormalities | 1 | 2002 | 20 | 0.210 |
Why?
|
Exome | 2 | 2020 | 127 | 0.210 |
Why?
|
Selection, Genetic | 4 | 2011 | 509 | 0.210 |
Why?
|
Trans-Activators | 2 | 2018 | 443 | 0.210 |
Why?
|
Escherichia coli | 3 | 2001 | 605 | 0.200 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 135 | 0.200 |
Why?
|
Alleles | 7 | 2020 | 1132 | 0.200 |
Why?
|
Zinc | 1 | 2001 | 93 | 0.190 |
Why?
|
Heart Defects, Congenital | 2 | 2015 | 365 | 0.190 |
Why?
|
Photoreceptor Cells, Invertebrate | 1 | 2020 | 21 | 0.190 |
Why?
|
Species Specificity | 5 | 2010 | 685 | 0.190 |
Why?
|
Tracheoesophageal Fistula | 1 | 2020 | 12 | 0.180 |
Why?
|
Esophageal Atresia | 1 | 2020 | 14 | 0.180 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 197 | 0.180 |
Why?
|
Nucleotidyltransferases | 1 | 1999 | 31 | 0.170 |
Why?
|
Hyperhomocysteinemia | 1 | 1999 | 11 | 0.170 |
Why?
|
Oxidoreductases Acting on CH-NH Group Donors | 1 | 1999 | 19 | 0.170 |
Why?
|
Carrier Proteins | 1 | 2003 | 679 | 0.170 |
Why?
|
Folic Acid | 1 | 1999 | 63 | 0.160 |
Why?
|
Models, Molecular | 6 | 2015 | 1295 | 0.160 |
Why?
|
Carboxylic Ester Hydrolases | 3 | 1997 | 24 | 0.160 |
Why?
|
Radius | 2 | 2015 | 31 | 0.160 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2018 | 41 | 0.160 |
Why?
|
Mutation, Missense | 2 | 2013 | 276 | 0.160 |
Why?
|
Forkhead Box Protein O3 | 1 | 2018 | 21 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2018 | 386 | 0.160 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 1427 | 0.150 |
Why?
|
Kidney | 4 | 2015 | 1145 | 0.150 |
Why?
|
Esophagus | 2 | 2015 | 107 | 0.150 |
Why?
|
Transgenes | 3 | 2013 | 185 | 0.150 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 511 | 0.150 |
Why?
|
Spine | 2 | 2015 | 102 | 0.150 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 201 | 0.140 |
Why?
|
Trachea | 2 | 2015 | 291 | 0.140 |
Why?
|
Genetic Association Studies | 2 | 2015 | 294 | 0.140 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2016 | 79 | 0.140 |
Why?
|
Organogenesis | 1 | 2017 | 50 | 0.140 |
Why?
|
Urinary Tract | 1 | 2017 | 34 | 0.140 |
Why?
|
Methylmalonyl-CoA Mutase | 1 | 1996 | 1 | 0.140 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 1996 | 2 | 0.140 |
Why?
|
Diabetes Mellitus | 2 | 2013 | 743 | 0.140 |
Why?
|
Mesoderm | 1 | 2017 | 124 | 0.140 |
Why?
|
Autophagy | 1 | 2018 | 154 | 0.140 |
Why?
|
Metabolism, Inborn Errors | 2 | 2011 | 30 | 0.140 |
Why?
|
Zebrafish | 2 | 2017 | 316 | 0.140 |
Why?
|
In Situ Hybridization | 5 | 2014 | 312 | 0.130 |
Why?
|
DNA Mutational Analysis | 5 | 2015 | 531 | 0.130 |
Why?
|
Conserved Sequence | 4 | 2014 | 211 | 0.130 |
Why?
|
Urinary Bladder | 3 | 2014 | 246 | 0.130 |
Why?
|
Limb Deformities, Congenital | 1 | 2015 | 20 | 0.130 |
Why?
|
Cloaca | 1 | 2015 | 4 | 0.130 |
Why?
|
Mice | 12 | 2020 | 11710 | 0.130 |
Why?
|
Point Mutation | 1 | 1996 | 246 | 0.130 |
Why?
|
Genes, Homeobox | 1 | 1995 | 82 | 0.130 |
Why?
|
Male | 19 | 2016 | 42012 | 0.130 |
Why?
|
Phenotype | 6 | 2015 | 2435 | 0.130 |
Why?
|
Signal Transduction | 3 | 2018 | 3368 | 0.120 |
Why?
|
Anal Canal | 1 | 2015 | 88 | 0.120 |
Why?
|
Humans | 27 | 2020 | 88611 | 0.120 |
Why?
|
Chromosome Duplication | 1 | 2014 | 8 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 171 | 0.120 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 44 | 0.120 |
Why?
|
Cell Differentiation | 1 | 2020 | 1518 | 0.120 |
Why?
|
Organ Specificity | 2 | 2011 | 272 | 0.120 |
Why?
|
Animals, Genetically Modified | 3 | 2013 | 182 | 0.120 |
Why?
|
Diptera | 1 | 2014 | 43 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 59 | 0.110 |
Why?
|
Wnt Proteins | 1 | 2014 | 130 | 0.110 |
Why?
|
Hand Bones | 1 | 2013 | 1 | 0.110 |
Why?
|
Syndrome | 3 | 2004 | 448 | 0.110 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 566 | 0.110 |
Why?
|
Schizophrenia | 1 | 2016 | 477 | 0.110 |
Why?
|
Apoptosis | 2 | 2018 | 1718 | 0.110 |
Why?
|
Radiography | 2 | 2013 | 807 | 0.110 |
Why?
|
Chromosome Mapping | 2 | 1993 | 1077 | 0.110 |
Why?
|
Androgen-Binding Protein | 1 | 2012 | 7 | 0.110 |
Why?
|
Genome-Wide Association Study | 3 | 2015 | 1662 | 0.110 |
Why?
|
Diseases in Twins | 1 | 2012 | 65 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 1256 | 0.100 |
Why?
|
Female | 19 | 2018 | 45759 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 311 | 0.100 |
Why?
|
Gene Rearrangement | 1 | 2013 | 172 | 0.100 |
Why?
|
Prune Belly Syndrome | 1 | 2011 | 3 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1993 | 217 | 0.100 |
Why?
|
Receptor, Muscarinic M3 | 1 | 2011 | 12 | 0.100 |
Why?
|
Genes, Lethal | 1 | 2011 | 53 | 0.100 |
Why?
|
Ejaculation | 1 | 1991 | 9 | 0.100 |
Why?
|
Insect Hormones | 1 | 1991 | 28 | 0.100 |
Why?
|
Genetic Fitness | 1 | 2011 | 37 | 0.100 |
Why?
|
Genitalia, Male | 1 | 1991 | 24 | 0.100 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2011 | 173 | 0.100 |
Why?
|
Ovum | 2 | 2011 | 59 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2005 | 418 | 0.090 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2010 | 5 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2013 | 321 | 0.090 |
Why?
|
Cell Cycle Proteins | 3 | 2017 | 399 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2017 | 1214 | 0.090 |
Why?
|
DNA | 3 | 2003 | 1308 | 0.090 |
Why?
|
Protein Folding | 3 | 2013 | 285 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 1977 | 0.090 |
Why?
|
Janus Kinases | 1 | 2009 | 23 | 0.080 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2008 | 8 | 0.080 |
Why?
|
Infant, Small for Gestational Age | 1 | 2008 | 29 | 0.080 |
Why?
|
Genomic Imprinting | 1 | 2008 | 33 | 0.080 |
Why?
|
Prostate | 1 | 2012 | 392 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2001 | 1020 | 0.080 |
Why?
|
Protein Isoforms | 2 | 2020 | 273 | 0.080 |
Why?
|
Introns | 2 | 2013 | 298 | 0.080 |
Why?
|
Embryo, Nonmammalian | 3 | 2015 | 196 | 0.070 |
Why?
|
Gene Expression | 4 | 2015 | 1312 | 0.070 |
Why?
|
Embryonic Development | 1 | 2007 | 78 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2015 | 2009 | 0.070 |
Why?
|
Osteochondrodysplasias | 1 | 2005 | 11 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2015 | 1851 | 0.070 |
Why?
|
Genetic Complementation Test | 1 | 2005 | 97 | 0.060 |
Why?
|
Foot Deformities, Congenital | 1 | 2004 | 10 | 0.060 |
Why?
|
Hand Deformities, Congenital | 1 | 2004 | 15 | 0.060 |
Why?
|
Wings, Animal | 2 | 2017 | 96 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2009 | 434 | 0.060 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 863 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2018 | 2980 | 0.060 |
Why?
|
Gene Deletion | 1 | 2005 | 342 | 0.060 |
Why?
|
Gene Knockdown Techniques | 2 | 2015 | 247 | 0.060 |
Why?
|
Gene Regulatory Networks | 2 | 2020 | 307 | 0.060 |
Why?
|
Grasshoppers | 1 | 2003 | 13 | 0.060 |
Why?
|
Eye | 2 | 2013 | 111 | 0.060 |
Why?
|
INDEL Mutation | 2 | 2014 | 31 | 0.060 |
Why?
|
Caenorhabditis | 1 | 2002 | 7 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 634 | 0.050 |
Why?
|
RNA Splicing Factors | 1 | 2003 | 28 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2005 | 460 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 2399 | 0.050 |
Why?
|
Carbon-Sulfur Lyases | 1 | 2001 | 1 | 0.050 |
Why?
|
Amidohydrolases | 1 | 2001 | 18 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 478 | 0.050 |
Why?
|
Adolescent | 2 | 2013 | 9157 | 0.050 |
Why?
|
Databases, Genetic | 1 | 2003 | 263 | 0.050 |
Why?
|
Cloning, Molecular | 2 | 2001 | 647 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2008 | 2445 | 0.050 |
Why?
|
Endopeptidases | 1 | 2001 | 117 | 0.050 |
Why?
|
Spatio-Temporal Analysis | 1 | 2020 | 23 | 0.050 |
Why?
|
Phylogeny | 3 | 2014 | 1171 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2003 | 258 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2001 | 332 | 0.050 |
Why?
|
Ligands | 1 | 2001 | 440 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2001 | 487 | 0.040 |
Why?
|
Cytidine Triphosphate | 1 | 1999 | 2 | 0.040 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 1999 | 14 | 0.040 |
Why?
|
Crystallography | 1 | 1999 | 45 | 0.040 |
Why?
|
Models, Animal | 1 | 2020 | 276 | 0.040 |
Why?
|
Dimerization | 1 | 1999 | 143 | 0.040 |
Why?
|
Flavin-Adenine Dinucleotide | 1 | 1999 | 7 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2015 | 1790 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2000 | 275 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2010 | 98 | 0.040 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 1999 | 27 | 0.040 |
Why?
|
Chikungunya virus | 1 | 1998 | 3 | 0.040 |
Why?
|
Alphavirus Infections | 1 | 1998 | 4 | 0.040 |
Why?
|
Consanguinity | 2 | 2011 | 73 | 0.040 |
Why?
|
Sex Factors | 2 | 2011 | 1063 | 0.040 |
Why?
|
Carboxylesterase | 3 | 1997 | 10 | 0.040 |
Why?
|
X-Ray Diffraction | 1 | 1999 | 126 | 0.040 |
Why?
|
Prevalence | 1 | 2003 | 1248 | 0.040 |
Why?
|
Genome, Viral | 1 | 1998 | 78 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 1999 | 411 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2012 | 292 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 2019 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2014 | 1156 | 0.040 |
Why?
|
Cytoplasm | 1 | 2018 | 285 | 0.040 |
Why?
|
Pronephros | 1 | 2017 | 2 | 0.040 |
Why?
|
Imaginal Discs | 1 | 2017 | 11 | 0.040 |
Why?
|
Neurofibromin 2 | 1 | 2017 | 30 | 0.040 |
Why?
|
Germany | 1 | 2016 | 72 | 0.040 |
Why?
|
Larva | 1 | 2017 | 120 | 0.030 |
Why?
|
Methylmalonic Acid | 1 | 1996 | 6 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2013 | 2346 | 0.030 |
Why?
|
Cell Polarity | 1 | 2017 | 116 | 0.030 |
Why?
|
Vitamin B 12 | 1 | 1996 | 24 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 1057 | 0.030 |
Why?
|
Cohort Studies | 1 | 2003 | 2837 | 0.030 |
Why?
|
Nucleotides | 1 | 1996 | 97 | 0.030 |
Why?
|
Cilia | 1 | 2015 | 29 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 177 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 108 | 0.030 |
Why?
|
Heterozygote | 1 | 1996 | 372 | 0.030 |
Why?
|
Risk Assessment | 1 | 2003 | 2286 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2015 | 119 | 0.030 |
Why?
|
Gene Frequency | 1 | 2016 | 684 | 0.030 |
Why?
|
Gene Order | 1 | 2014 | 23 | 0.030 |
Why?
|
Genitalia | 1 | 2014 | 21 | 0.030 |
Why?
|
Sulfotransferases | 1 | 2013 | 19 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 1996 | 229 | 0.030 |
Why?
|
Heparitin Sulfate | 1 | 2013 | 27 | 0.030 |
Why?
|
Protein Transport | 1 | 2015 | 419 | 0.030 |
Why?
|
Glucose Dehydrogenases | 1 | 1993 | 2 | 0.030 |
Why?
|
Glucose 1-Dehydrogenase | 1 | 1993 | 2 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2014 | 205 | 0.030 |
Why?
|
Dosage Compensation, Genetic | 1 | 2013 | 17 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2013 | 89 | 0.030 |
Why?
|
Urethra | 1 | 2014 | 115 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2013 | 46 | 0.030 |
Why?
|
Gene Dosage | 1 | 2013 | 208 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 2013 | 124 | 0.030 |
Why?
|
RNA, Untranslated | 1 | 2013 | 65 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2017 | 686 | 0.030 |
Why?
|
Twins, Dizygotic | 1 | 2012 | 40 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2013 | 371 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 2012 | 57 | 0.030 |
Why?
|
RNA Interference | 1 | 2013 | 378 | 0.030 |
Why?
|
Genetic Speciation | 1 | 2014 | 115 | 0.030 |
Why?
|
Bacteria | 1 | 1996 | 468 | 0.030 |
Why?
|
Odds Ratio | 1 | 2014 | 686 | 0.030 |
Why?
|
Computational Biology | 1 | 2015 | 542 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2014 | 368 | 0.030 |
Why?
|
Haplotypes | 1 | 2014 | 637 | 0.030 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 2011 | 21 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2011 | 51 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 697 | 0.020 |
Why?
|
Sex Determination Analysis | 1 | 1991 | 18 | 0.020 |
Why?
|
Genome | 2 | 2013 | 385 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 269 | 0.020 |
Why?
|
RNA | 1 | 2015 | 575 | 0.020 |
Why?
|
Blastoderm | 1 | 2011 | 33 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2017 | 1647 | 0.020 |
Why?
|
Adult | 2 | 2016 | 26348 | 0.020 |
Why?
|
Genotype | 1 | 2015 | 1867 | 0.020 |
Why?
|
Genes | 1 | 1991 | 305 | 0.020 |
Why?
|
Time Factors | 2 | 2012 | 5319 | 0.020 |
Why?
|
Hybridization, Genetic | 1 | 2010 | 106 | 0.020 |
Why?
|
Models, Biological | 1 | 2017 | 1764 | 0.020 |
Why?
|
Blotting, Western | 1 | 1991 | 797 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 543 | 0.020 |
Why?
|
Fushi Tarazu Transcription Factors | 1 | 2009 | 5 | 0.020 |
Why?
|
Compound Eye, Arthropod | 1 | 2009 | 7 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2009 | 58 | 0.020 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2008 | 33 | 0.020 |
Why?
|
Transcriptome | 1 | 2013 | 623 | 0.020 |
Why?
|
Lymphocytes | 1 | 2010 | 470 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 891 | 0.020 |
Why?
|
Models, Genetic | 1 | 2014 | 942 | 0.020 |
Why?
|
Nervous System | 1 | 2009 | 88 | 0.020 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2008 | 122 | 0.020 |
Why?
|
RNA, Long Noncoding | 1 | 2008 | 116 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2011 | 1988 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 2406 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 927 | 0.020 |
Why?
|
Phosphorylation | 1 | 2009 | 1129 | 0.020 |
Why?
|
Turkey | 1 | 2005 | 21 | 0.020 |
Why?
|
Enalapril | 1 | 2005 | 13 | 0.020 |
Why?
|
Losartan | 1 | 2005 | 29 | 0.020 |
Why?
|
Nephrotic Syndrome | 1 | 2005 | 33 | 0.020 |
Why?
|
Child | 2 | 2008 | 7089 | 0.020 |
Why?
|
Genes, Recessive | 1 | 2005 | 87 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 116 | 0.020 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 45 | 0.020 |
Why?
|
Arginine | 1 | 2005 | 138 | 0.020 |
Why?
|
Homozygote | 1 | 2005 | 202 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 90 | 0.020 |
Why?
|
Oocytes | 2 | 2003 | 221 | 0.020 |
Why?
|
Trinucleotide Repeats | 1 | 2004 | 32 | 0.020 |
Why?
|
Protein Denaturation | 1 | 2004 | 106 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2005 | 338 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2004 | 231 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 2498 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2005 | 624 | 0.010 |
Why?
|
DNA Methylation | 1 | 2008 | 656 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 741 | 0.010 |
Why?
|
Juvenile Hormones | 1 | 2003 | 4 | 0.010 |
Why?
|
RNA Splicing | 1 | 2004 | 150 | 0.010 |
Why?
|
Proteins | 1 | 2008 | 786 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 391 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2004 | 441 | 0.010 |
Why?
|
Stem Cells | 1 | 2004 | 371 | 0.010 |
Why?
|
Biopsy | 1 | 2005 | 1187 | 0.010 |
Why?
|
Child, Preschool | 1 | 2008 | 3678 | 0.010 |
Why?
|
Insect Vectors | 1 | 1998 | 10 | 0.010 |
Why?
|
Culicidae | 1 | 1998 | 8 | 0.010 |
Why?
|
Uganda | 1 | 1998 | 36 | 0.010 |
Why?
|
Vero Cells | 1 | 1998 | 101 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2005 | 3655 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1997 | 73 | 0.010 |
Why?
|
Middle Aged | 1 | 2016 | 25699 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1997 | 153 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2005 | 8178 | 0.010 |
Why?
|
Physical Chromosome Mapping | 1 | 1983 | 27 | 0.000 |
Why?
|
Poly A | 1 | 1983 | 23 | 0.000 |
Why?
|
Xenopus laevis | 1 | 1983 | 137 | 0.000 |
Why?
|
Isoenzymes | 1 | 1983 | 273 | 0.000 |
Why?
|